The Biotech sector (via SPDR S&P Biotech ETF (NYSE:XBI), below) is threatening to break out of a month-and-a-half long consolidation early in a new daily cycle. Remember earlier in the year when so many said I was crazy for recommending biotech?
The Biotech sector (via SPDR S&P Biotech ETF (NYSE:XBI), below) is threatening to break out of a month-and-a-half long consolidation early in a new daily cycle. Remember earlier in the year when so many said I was crazy for recommending biotech?